Arpita Ray-Sinha

Arpita Ray-Sinha is a Senior Principal Scientist at BenevolentAI, specializing in drug discovery with extensive experience in AI/ML-based target identification programs, particularly in oncology and neuro-degenerative disease areas. Notable accomplishments include leading a small molecule drug discovery program from target identification to pre-IND application. Prior roles include Research Scientist at Kesios Therapeutics and a project focused on drug discovery and target validation at The Institute of Cancer Research, where expertise in cell-based assays and molecular biology techniques was applied to identify biomarkers. Arpita's academic background includes a Master's Degree in Physiology from the University of Liverpool and a Ph.D. in Cell Biology and Biochemistry from The University of Manchester.